FindTrial
Sign In

An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)

An Epidemiological Study to Investigate the Characteristics of RSV Infection in Adult Hematopoietic Cell Transplant Recipients or Hematological Malignancies Patients in Tianjin HI (Hematology Institute)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06490549
Enrollment
500
Registered
2024-07-08
Start date
2023-11-30
Completion date
2025-06-20
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RSV Infection

Brief summary

This primary objective of this study is to describe the incidence of RSV infection in adult hematopoietic cell transplant recipients OR hematological malignancies patients in Tianjin HI.

Interventions

OTHERRSV infection observation cohort

No intervention; Epidemiological Study. Participants will receive standard care based on local clinical practice

Sponsors

Institute of Hematology & Blood Diseases Hospital, China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\) Aged ≥ 18 years old. 2) Receiving hematopoietic stem cell transplantation; OR being diagnosed with hematological malignancies (including but not limited to leukemia, lymphoma, and multiple myeloma) and receiving chemotherapy. 3\) New onset of respiratory symptoms; OR exacerbation of existing chronic respiratory symptoms (such as previously diagnosed chronic runny nose, seasonal allergies, chronic lung disease, etc.). 4\) Willing to sign an informed consent form, able to understand and willing to follow the study protocol.

Exclusion criteria

* Unwillingness to sign an informed consent form.

Design outcomes

Primary

MeasureTime frameDescription
the incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the study site1 yearinfection incidence
the Incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the hospital1 yearinfection incidence

Secondary

MeasureTime frameDescription
the clinical characteristics of RSV infection1 yearsymptoms description and scoring of RSV infection
Clinical outcome and relevant risk factor of RSV infection1 yearClinical outcome and relevant risk factor of RSV infection
Virological characteristics of RSV infection from D1 through D28, D42 or even longer1 yearClinical outcome and relevant risk factor of RSV infection

Countries

China

Contacts

Primary ContactErlie Jiang, MD
jiangerlie@ihcams.ac.cn+86-15122538106

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026